Compare BIO-TECHNE Corp (TECH) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Warner Music Group Corp — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Warner Music Group Corp trades at $28.87 (market cap $14.73B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Warner Music Group Corp for 96 Days on average.
| TECH | WMG | |
|---|---|---|
Market Cap | $11.37B | $14.73B |
Volume | 3,153,511 | 2,404,416 |
Sector | Health | Media |
52-Week High | $72.61 | $34.72 |
52-Week Low | $43.31 | $23.65 |
Typical Hold Time | 63 Days | 96 Days |
Enterprise Value | $11.40B | $19.03B |
Dividend Yield | 0.44% | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Warner Music Group (WMG) trades at $28.91, up 4.71% with strong technical momentum and bullish moving average signals. The company delivered Q2 2026 earnings beat with EPS of $0.38 versus $0.34 expected, continuing positive earnings momentum. Recent partnerships with AI music platforms and strategic licensing renewals highlight growth initiatives in the evolving music industry landscape.
WMG presents compelling value with analyst consensus target of $39.50 (36% upside) and strong institutional buying. However, elevated P/E of 22.52 and recent CFO departure pose execution risks. The stock's 92.72% ROE demonstrates exceptional capital efficiency, but investors should monitor AI integration execution and streaming revenue sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
